+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Selecta Biosciences - logo

Selecta Biosciences was founded in 2007 and is headquartered in Watertown, Massachusetts. It is a biopharmaceutical company, they create biological therapies that fight against unwanted immune responses. Selecta Biosciences specialise in Synthetic Vaccine Particles (SVP™) technology platform. They use this treatment to fight rare and serious diseases. Selectas current pipeline includes: SVP- enabled enzyme, oncology and gene therapies.

From
From
From
From
From
Hyperuricemia - Pipeline Review, H2 2020 - Product Thumbnail Image

Hyperuricemia - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 86 Pages
From
Methylmalonic acidaemia - Pipeline Insight, 2022 - Product Thumbnail Image

Methylmalonic acidaemia - Pipeline Insight, 2022

  • Clinical Trials
  • March 2022
  • 60 Pages
From
Pompe Disease - Pipeline Insight, 2020 - Product Thumbnail Image

Pompe Disease - Pipeline Insight, 2020

  • Clinical Trials
  • September 2020
  • 90 Pages
From
Crigler-Najjar Syndrome - Pipeline Review, H2 2020 - Product Thumbnail Image

Crigler-Najjar Syndrome - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 39 Pages
From
From
Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018 - Product Thumbnail Image

Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2018

  • Clinical Trials
  • September 2018
  • 52 Pages
From
Loading Indicator